» Articles » PMID: 28939606

Alterations in Gp37 Expand the Host Range of a T4-Like Phage

Overview
Date 2017 Sep 24
PMID 28939606
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

The use of phages as antibacterial agents is limited by their generally narrow host ranges. The aim of this study was to make a T4-like phage, WG01, obtain the host range of another T4-like phage, QL01, by replacing its host-determinant gene region with that of QL01. This process triggered a direct expansion of the WG01 host range. The offspring of WG01 obtained the host ranges of both QL01 and WG01, as well as the ability to infect eight additional host bacteria in comparison to the wild-type strains. WQD had the widest host range; therefore, the corresponding fragments, named QD, could be used for constructing a homologous sequence library. Moreover, after a sequencing analysis of gene 37, we identified two different mechanisms responsible for the expanded host range: (i) the first generation of WG01 formed chimeras without mutations, and (ii) the second generation of WG01 mutants formed from the chimeras. The expansion of the host range indicated that regions other than the C-terminal region may indirectly change the receptor specificity by altering the supportive capacity of the binding site. Additionally, we also found the novel means by which subsequent generations expanded their host ranges, namely, by exchanging gene 37 to acquire a wider temperature range for lysis. The method developed in this work offers a quick way to change or expand the host range of a phage. Future clinical applications for screening phages against a given clinical isolate could be achieved after acquiring more suitable homologous sequences. T4-like phages have been established as safe in numerous phage therapy applications. The primary drawbacks to the use of phages as therapeutic agents include their highly specific host ranges. Thus, changing or expanding the host range of T4-like phages is beneficial for selecting phages for phage therapy. In this study, the host range of the T4-like phage WG01 was expanded using genetic manipulation. The WG01 derivatives acquired a novel means of expanding their host ranges by acquiring a wider temperature range for lysis. A region was located that had the potential to be used as a sequence region for homologous sequence recombination.

Citing Articles

Advancing Phage Therapy: A Comprehensive Review of the Safety, Efficacy, and Future Prospects for the Targeted Treatment of Bacterial Infections.

Palma M, Qi B Infect Dis Rep. 2024; 16(6):1127-1181.

PMID: 39728014 PMC: 11675988. DOI: 10.3390/idr16060092.


A Novel Phage against Bearing a Unique Gene of Intergeneric Origin.

Vasileiadis A, Bozidis P, Konstantinidis K, Kesesidis N, Potamiti L, Kolliopoulou A Curr Issues Mol Biol. 2024; 46(9):9312-9329.

PMID: 39329903 PMC: 11430396. DOI: 10.3390/cimb46090551.


Antibacterial activity evaluation of a novel K3-specific phage against Acinetobacter baumannii and evidence for receptor-binding domain transfer across morphologies.

Zheng X, Liu M, Li P, Xu S, Chen L, Xu G Virol Sin. 2024; 39(5):767-781.

PMID: 39098716 PMC: 11738781. DOI: 10.1016/j.virs.2024.08.002.


Genomic and biological insights of bacteriophages JNUWH1 and JNUWD in the arms race against bacterial resistance.

Zhang H, You J, Pan X, Hu Y, Zhang Z, Zhang X Front Microbiol. 2024; 15:1407039.

PMID: 38989022 PMC: 11233448. DOI: 10.3389/fmicb.2024.1407039.


In situ targeted base editing of bacteria in the mouse gut.

Brodel A, Charpenay L, Galtier M, Fuche F, Terrasse R, Poquet C Nature. 2024; 632(8026):877-884.

PMID: 38987595 PMC: 11338833. DOI: 10.1038/s41586-024-07681-w.


References
1.
Wittebole X, De Roock S, Opal S . A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens. Virulence. 2013; 5(1):226-35. PMC: 3916379. DOI: 10.4161/viru.25991. View

2.
Kaper J, Nataro J, Mobley H . Pathogenic Escherichia coli. Nat Rev Microbiol. 2004; 2(2):123-40. DOI: 10.1038/nrmicro818. View

3.
Diarra M, Malouin F . Antibiotics in Canadian poultry productions and anticipated alternatives. Front Microbiol. 2014; 5:282. PMC: 4060556. DOI: 10.3389/fmicb.2014.00282. View

4.
Bartual S, Otero J, Garcia-Doval C, Llamas-Saiz A, Kahn R, Fox G . Structure of the bacteriophage T4 long tail fiber receptor-binding tip. Proc Natl Acad Sci U S A. 2010; 107(47):20287-92. PMC: 2996694. DOI: 10.1073/pnas.1011218107. View

5.
Chen M, Zhang L, Xin S, Yao H, Lu C, Zhang W . Inducible Prophage Mutant of Can Lyse New Host and the Key Sites of Receptor Recognition Identification. Front Microbiol. 2017; 8:147. PMC: 5285337. DOI: 10.3389/fmicb.2017.00147. View